Enzo Biochem's Q3 Revenues Rise 22 Percent

Enzo's life sciences products business posted a 44 percent revenue gain due primarily to the addition of Biomol and Assay Designs over the past year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories